Palisade bio announces inducement grants under nasdaq listing rule 5635(c)(4)

Carlsbad, ca, sept. 23, 2022 (globe newswire) -- palisade bio, inc.  (nasdaq: pali), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (gi) complications, today announced that it had made equity grants to two new employees under its 2021 inducement plan.
PALI Ratings Summary
PALI Quant Ranking